Germany’s BioNTech made 12.95 billion euros in profits on 17.3 billion euros in revenues for a whopping 75% profit margin, compared to Pfizer’s “high 20s” on COVID-19 vaccine revenues and 34.6% profit margin on all revenues.
This post was created with our nice and easy submission form. Create your post!
Comments
Loading…